Alembic Pharmaceuticals Limited APLLTD

Latest filings

• Routine15 10 Nov, 16:35 · BSE
  Please find attached herewith the Transcript of Post Results Conference Call held on 4th November, 2026.
• Routine15 10 Nov, 16:34 · NSE
  Transcript
• Routine15 5 Nov, 12:31 · NSE
  Newspaper Publication related to Unaudited Financial Results of the Company for the quarter ended 30th September, 2026.
• Approval76 4 Nov, 21:59 · NSE
  Receives USFDA Final Approval for Olopatadine Hydrochloride Ophthalmic Solution USP, 0.7% (OTC).
• Routine15 4 Nov, 19:03 · NSE
  Link of Audio Recording
• Management change73 4 Nov, 15:11 · NSE
  General Updates: Updated Details of Key Managerial Personnel pursuant to Regulation 30(5) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
• General25 4 Nov, 14:40 · BSE
  Please find attached Press Release
• Routine15 4 Nov, 14:38 · BSE
  Please find attached Investor Presentation for the Quarter and Half Year Ended September 30, 2026.
• General30 4 Nov, 14:34 · BSE
  Please find attached Press Release for the Quarter and Half Year Ended September 30, 2026.
• Results73 4 Nov, 14:31 · BSE
  Please find attached Unaudited Financial Results for the Quarter and Half Year Ended September 30, 2026.

Shown 15 minutes after publication. Real time with Pro.